AlphaYouIRD: Foundation Fighting Blindness Retinal Degeneration Fund; Foundation Fighting Blindness, Inc. discloses a sale
By AlphaYouPublished Form 4
Foundation Fighting Blindness Retinal Degeneration Fund; Foundation Fighting Blindness, Inc.
Reporting filer
Foundation Fighting Blindness Retinal Degeneration Fund; Foundation Fighting Blindness, Inc. reported Sale in Opus Genetics, Inc.: 556000 units of Common Stock, dated 2026-09-30. The full Form 4 contains 1 transaction entry.
- Disclosed
- Oct 2, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Foundation Fighting Blindness Retinal Degeneration Fund; Foundation Fighting Blindness, Inc. | 2026-09-30 | S | Sale | 556000 | 4.9568 | 3,236,171 | 2 days | Filed terms
|
Common Stock
- Owner
- Foundation Fighting Blindness Retinal Degeneration Fund; Foundation Fighting Blindness, Inc.
- Date
- 2026-09-30
- Code
- S
- Action
- Sale
- Quantity
- 556000
- Price
- 4.9568
- Following holdings
- 3,236,171
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-30
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 556000
- transaction Price Per Share: 4.9568
- id: F1
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 3236171
- direct Or Indirect Ownership: D
- id: F2
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Foundation Fighting Blindness Retinal Degeneration Fund: Director, Other reporting owner.
- Foundation Fighting Blindness, Inc.: Director, Other reporting owner.
- F1: This transaction was executed in multiple trades at prices ranging from $4.95 to $5.29. The price reported in Column 4 is a weighted average price. The Reporting Persons hereby undertake to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- F2: Foundation Fighting Blindness, Inc. ("FFB") is the sole member of Foundation Fighting Blindness Retinal Degeneration Fund ("RDF") and may be deemed to beneficially own the securities owned directly by RDF. RDF has the power to vote and dispose of any securities directly owned by RDF. RDF's board of directors makes voting and investment decisions regarding securities held by RDF, subject to certain approval rights of the board of directors of FFB with respect to transactions exceeding a certain threshold.
Original sources
Prepared automatically from public filing data. Report a correction.